Infralow neurofeedback in the treatment of substance use disorders: a randomized controlled trial.
J Psychiatry Neurosci. 2022 Jun 15;47(3):E222-E229. doi: 10.1503/jpn.210202. Print 2022 May-Jun.
J Psychiatry Neurosci. 2022.
PMID: 35705204
Clinical Trial.